Leonteq Securities AG’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5K Hold
171
﹤0.01% 999
2026
Q1
$14.7K Hold
171
﹤0.01% 1038
2025
Q4
$14.9K Buy
171
+150
+714% +$11.4K ﹤0.01% 1149
2025
Q3
$1.2K Hold
21
﹤0.01% 1243
2025
Q2
$1.24K Hold
21
﹤0.01% 1192
2025
Q1
$1.54K Sell
21
-2,459
-99% -$203K ﹤0.01% 1155
2024
Q4
$205K Buy
2,480
+2,438
+5,805% +$192K 0.01% 539
2024
Q3
$3K Hold
42
﹤0.01% 1076
2024
Q2
$2.88K Hold
42
﹤0.01% 1087
2024
Q1
$2.25K Hold
42
﹤0.01% 1128
2023
Q4
$2.24K Sell
42
-6
-13% -$292 ﹤0.01% 1117
2023
Q3
$2.38K Hold
48
﹤0.01% 1122
2023
Q2
$2.86K Hold
48
﹤0.01% 1145
2023
Q1
$2.72K Hold
48
﹤0.01% 1141
2022
Q4
$3.56K Hold
48
﹤0.01% 1162
2022
Q3
$2.86K Sell
48
-344
-88% -$20.7K ﹤0.01% 1168
2022
Q2
$22K Buy
392
+60
+18% +$3.94K ﹤0.01% 964
2022
Q1
$24.5K Sell
332
-27
-8% -$1.88K ﹤0.01% 978
2021
Q4
$25.9K Hold
359
﹤0.01% 1004
2021
Q3
$27.5K Buy
+359
New +$28.8K ﹤0.01% 927

Other funds holding GMED

Leonteq Securities AG's GMED Position: Q2 2026 in Review

Leonteq Securities AG held its Globus Medical (GMED) position steady in Q2 2026 at 171 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Leonteq Securities AG first reported a position in GMED in Q3 2021 and has held it in 20 quarters since. The position peaked at $205K in Q4 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Leonteq Securities AG held 171 shares of Globus Medical worth $13.5K as of Q2 2026.
  • Leonteq Securities AG left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #999 holding.
  • Leonteq Securities AG first reported a position in Globus Medical in Q3 2021 and has held it in 20 quarters since.
  • Leonteq Securities AG's Globus Medical position peaked at $205K in Q4 2024.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.